Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review

INTRODUCTION: This systematic review addresses the use of epidermal growth factor receptor (egfr) inhibitors in three populations of advanced non-small-cell lung cancer (nsclc) patients—unselected, selected, and molecularly selected—in three treatment settings: first line, second line, and maintenan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Ellis, P.M., Coakley, N., Feld, R., Kuruvilla, S., Ung, Y.C.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2015
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462541/
https://ncbi.nlm.nih.gov/pubmed/26089730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.22.2566
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados